In 1969, apt. Drs. Rudy Soetikno, a young pharmacist serving in the Indonesian Army, noted the scarce supply of medicine around him. To alleviate this situation, he decided to utilise his knowledge of medicine, setting up a small pharmacy with friends to produce tablets. This small pharmacy rapidly acquired a reputation for producing highly effective prescription drugs, facilitating its expansion into other pharmaceuticals, facilities, and markets. By 1978, its products were available across all parts of Indonesia. Its name, “Dexa”, was derived from the Greek word for ten, a symbol of perfection.
Thus began Dexa Group, now among Southeast Asia’s largest pharmaceutical providers and a key strategic asset for Indonesia. The group applies its expertise in discovery, formulation, manufacturing, and marketing to supply highly sophisticated pharmaceuticals, nutraceuticals, supplements, and herbal medicines throughout Southeast Asia. It still maintains its trademark relentless emphasis on producing medicines of the highest quality. In fact, Dexa Group also works closely with the Indonesian Pharmaceutical Association to improve compliance standards across the entire industry.